<table><tr><th>Template</th><th>Technical</th></tr><tr><td>3.1.1: Population Level Summary</td><td>Amendment Details: Amendment Scope Enrollment Description</td></tr><tr><td>3.2.1: Table of Estimand Characteristics including Endpoint at a minimum 2</td><td>1.1.2: Sponsors Investigational Product Codes 2</td></tr><tr><td>3.3.1: Table of Estimand Characteristics including endpoint at a minimum</td><td>1.1.2: NonProprietary Names</td></tr><tr><td>11.3.2: Informed Consent for Use of Remaining Samples in Exploratory Research</td><td>3.1.X: Population-level Summary</td></tr><tr><td>12.2: Country-Region Specific Protocol Clarifications</td><td>3.2.X: Enter Table of Estimand Characteristics including Endpoint at a minimum</td></tr><tr><td>12.3: Previous Amendment Number</td><td>3.2.X: Population 2</td></tr><tr><td>12.3: enter sponsor approval date</td><td>3.2.X: Treatment 2</td></tr><tr><td>: </td><td>3.2.X: Endpoint 2</td></tr><tr><td>: </td><td>3.2.X: Population-level Summary 2</td></tr><tr><td>: </td><td>3.2.X: Intercurrent Event 1 Strategy 2</td></tr><tr><td>: </td><td>3.3.X: Enter Table of Estimand Characteristics</td></tr><tr><td>: </td><td>3.3.X: Population 3</td></tr><tr><td>: </td><td>3.3.X: Treatment 3</td></tr><tr><td>: </td><td>3.3.X: Endpoint 3</td></tr><tr><td>: </td><td>3.3.X: Population-level Summary 3</td></tr><tr><td>: </td><td>3.3.X: Description of Intercurrent Event 2</td></tr><tr><td>: </td><td>3.3.X: Intercurrent Event - Strategy</td></tr><tr><td>: </td><td>11.3.2: Informed consent for Use of Remaining Samples in Exploratory Research</td></tr><tr><td>: </td><td>12.2: Country-Region-specific Protocol Clarification</td></tr><tr><td>: </td><td>12.3: amendment Identifier</td></tr><tr><td>: </td><td>12.3: Sponsor Approval Date 2</td></tr></table>